EV/EBITDA
-0.12
-0.04-50.00%
Fri, 07 Feb 2025 21:00:02 GMT
Summary
- As of February 8, 2025, AVTX EV/EBITDA is -0.12, with a fall of -0.04 (-50.00%) during the most recent trading day.
- Over the past year, AVTX EV/EBITDA has dropped by -0.24 (-200.00%).
- AVTX EV/EBITDA is now -100.75% below its all-time high of 16.09.
Performance
AVTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
AVTX EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | -50.0% | +57.8% | +1.9% |
1 m1 month | -700.0% | +608.3% | +6.4% |
3 m3 months | +91.9% | -91.9% | -36.6% |
6 m6 months | -103.9% | +105.3% | -24.9% |
ytdytd | -220.0% | +220.2% | +10.1% |
1 y1 year | -200.0% | +226.4% | +88.0% |
5 y5 years | +100.0% | -100.0% | -99.9% |
AVTX EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -128.6% | -0.21 | +42.9% | |
3 m | 3-month | 0.42 | -128.6% | -1.64 | +92.7% |
6 m | 6-month | 3.09 | -103.9% | -1.64 | +92.7% |
1 y | 1-year | 4.10 | -102.9% | -1.64 | +92.7% |
3 y | 3-year | 4.10 | -102.9% | -2.43 | +95.1% |
5 y | 5-year | 4.10 | -102.9% | -2618 | +100.0% |
alltime | all time | 16.09 | -100.8% | -5768 | +100.0% |
Avalo Therapeutics EV/EBITDA History
Date | Value |
---|---|
2025 | -0.12(-220.0%) |
2024 | 0.10(-1100.0%) |
2023 | -0.01(-99.3%) |
2022 | -1.46(-31.1%) |
2021 | -2.12(-99.4%) |
Date | Value |
---|---|
2020 | -381.30(-88.4%) |
2019 | -3300.24(+27.9%) |
2018 | -2579.92(<-9900.0%) |
2017 | 6.84(-2054.3%) |
2016 | -0.35(-71.1%) |
2015 | -1.21 |
FAQ
- What is Avalo Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Avalo Therapeutics?
- What is AVTX EV/EBITDA year-to-date change?
- What is Avalo Therapeutics EV/EBITDA year-on-year change?
What is Avalo Therapeutics EV/EBITDA?
The current EV/EBITDA of AVTX is -0.12
What is the all time high EV/EBITDA for Avalo Therapeutics?
Avalo Therapeutics all-time high EV/EBITDA is 16.09
What is AVTX EV/EBITDA year-to-date change?
Avalo Therapeutics EV/EBITDA has changed by -0.22 (-220.00%) since the beginning of the year
What is Avalo Therapeutics EV/EBITDA year-on-year change?
Over the past year, AVTX EV/EBITDA has changed by -0.24 (-200.00%)